Búsqueda | Portal de Búsqueda de la BVS

1.

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.

Flood, Veronica H; Christopherson, Pamela A; Gill, Joan Cox; Friedman, Kenneth D; Haberichter, Sandra L; Bellissimo, Daniel B; Udani, Rupa A; Dasgupta, Mahua; Hoffmann, Raymond G; Ragni, Margaret V; Shapiro, Amy D; Lusher, Jeanne M; Lentz, Steven R; Abshire, Thomas C; Leissinger, Cindy; Hoots, W Keith; Manco-Johnson, Marilyn J; Gruppo, Ralph A; Boggio, Lisa N; Montgomery, Kate T; Goodeve, Anne C; James, Paula D; Lillicrap, David; Peake, Ian R; Montgomery, Robert R.

Blood ; 127(20): 2481-8, 2016 05 19.

Artículo en Inglés | MEDLINE | ID: mdl-26862110

2.

A longer acting rFVIII, safe and effective.

Lusher, Jeanne M.

Blood ; 123(3): 304-5, 2014 Jan 16.

Artículo en Inglés | MEDLINE | ID: mdl-24434992

3.

No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.

Flood, Veronica H; Friedman, Kenneth D; Gill, Joan Cox; Haberichter, Sandra L; Christopherson, Pamela A; Branchford, Brian R; Hoffmann, Raymond G; Abshire, Thomas C; Dunn, Amy L; Di Paola, Jorge A; Hoots, W Keith; Brown, Deborah L; Leissinger, Cindy; Lusher, Jeanne M; Ragni, Margaret V; Shapiro, Amy D; Montgomery, Robert R.

Blood ; 121(18): 3742-4, 2013 May 02.

Artículo en Inglés | MEDLINE | ID: mdl-23520336

4.

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.

Bellissimo, Daniel B; Christopherson, Pamela A; Flood, Veronica H; Gill, Joan Cox; Friedman, Kenneth D; Haberichter, Sandra L; Shapiro, Amy D; Abshire, Thomas C; Leissinger, Cindy; Hoots, W Keith; Lusher, Jeanne M; Ragni, Margaret V; Montgomery, Robert R.

Blood ; 119(9): 2135-40, 2012 Mar 01.

Artículo en Inglés | MEDLINE | ID: mdl-22197721

5.

Emergency department visits in children with hemophilia.

Özgönenel, Bülent; Zia, Ayesha; Callaghan, Michael U; Chitlur, Meera; Rajpurkar, Madhvi; Lusher, Jeanne M.

Pediatr Blood Cancer ; 60(7): 1188-91, 2013 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-23192828

6.

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.

Flood, Veronica H; Gill, Joan Cox; Morateck, Patricia A; Christopherson, Pamela A; Friedman, Kenneth D; Haberichter, Sandra L; Branchford, Brian R; Hoffmann, Raymond G; Abshire, Thomas C; Di Paola, Jorge A; Hoots, W Keith; Leissinger, Cindy; Lusher, Jeanne M; Ragni, Margaret V; Shapiro, Amy D; Montgomery, Robert R.

Blood ; 116(2): 280-6, 2010 Jul 15.

Artículo en Inglés | MEDLINE | ID: mdl-20231421

7.

Thromboelastography in children with coagulation factor deficiencies.

Chitlur, Meera; Warrier, Indira; Rajpurkar, Madhvi; Hollon, Wendy; Llanto, Lolita; Wiseman, Carol; Lusher, Jeanne M.

Br J Haematol ; 142(2): 250-6, 2008 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-18492116

8.

Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia.

Wang, Zhihong J; Onwuzurike, Nkechi; Callaghan, Michael U; Rajpurkar, Madhvi; Chitlur, Meera; Lusher, Jeanne M.

Pediatr Blood Cancer ; 51(3): 416-8, 2008 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-18493997

9.

How do you treat bleeding disorders with desmopressin?

Ozgönenel, Bülent; Rajpurkar, Madhvi; Lusher, Jeanne M.

Postgrad Med J ; 83(977): 159-63, 2007 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-17344569

10.

Milestones in hemophilia and concepts in future clinical trial design.

Lusher, Jeanne M.

Semin Hematol ; 43(1 Suppl 1): S84-7, 2006 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-16427391

11.

Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation.

Kreuz, Wolfhart; Gill, Joan C; Rothschild, Chantal; Manco-Johnson, Marilyn J; Lusher, Jeanne M; Kellermann, Elke; Gorina, Eduard; Larson, Peter J.

Thromb Haemost ; 93(3): 457-67, 2005 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-15735795

12.

Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonance.

Lewis, Kenneth B; Hughes, Richard J; Epstein, Melinda S; Josephson, Neil C; Kempton, Christine L; Kessler, Craig M; Key, Nigel S; Howard, Tom E; Kruse-Jarres, Rebecca; Lusher, Jeanne M; Walsh, Christopher E; Watts, Raymond G; Ettinger, Ruth A; Pratt, Kathleen P.

PLoS One ; 8(5): e61120, 2013.

Artículo en Inglés | MEDLINE | ID: mdl-23667433

13.

A community-based partnership to promote information infrastructure for bleeding disorders.

Aschman, Diane J; Abshire, Thomas C; Shapiro, Amy D; Lusher, Jeanne M; Forsberg, Ann D; Kulkarni, Roshni.

Am J Prev Med ; 41(6 Suppl 4): S332-7, 2011 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-22099355

14.

Fibrinolytic parameters in children with noncatheter thrombosis: a pilot study.

Kupesiz, O Alphan; Chitlur, Meera B; Hollon, Wendy; Tosun, Ozgun; Thomas, Ronald; Warrier, Indira; Lusher, Jeanne M; Rajpurkar, Madhvi.

Blood Coagul Fibrinolysis ; 21(4): 313-9, 2010 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-20305541

15.

Highlights from the XXV International Congress of the World Federation of Hemophilia. May 19-24, 2002, Seville, Spain.

Lusher, Jeanne M.

MedGenMed ; 4(3): 14, 2002 Jun 18.

Artículo en Inglés | MEDLINE | ID: mdl-12466757

16.

Evolution of recombinant factor VIII safety: KOGENATE and Kogenate FS/Bayer.

Lusher, Jeanne M; Scharrer, Inge.

Int J Hematol ; 90(4): 446-454, 2009 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-19882376

17.

Pediatric reference values for molecular markers in hemostasis.

Sosothikul, Darintr; Seksarn, Panya; Lusher, Jeanne M.

J Pediatr Hematol Oncol ; 29(1): 19-22, 2007 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-17230062

18.

The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B.

Shapiro, Amy D; Di Paola, Jorge; Cohen, Alice; Pasi, K John; Heisel, Margaret A; Blanchette, Victor S; Abshire, Thomas C; Hoots, W Keith; Lusher, Jeanne M; Negrier, Claude; Rothschild, Chantal; Roth, David A.

Blood ; 105(2): 518-25, 2005 Jan 15.

Artículo en Inglés | MEDLINE | ID: mdl-15383463

19.

First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor development.

Lusher, Jeanne M.

Semin Thromb Hemost ; 28(3): 273-6, 2002 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-12098088

20.

Congenital Hemorrhagic Disorders: New Insights into the Pathophysiology and Treatment of Hemophilia.

Hedner, Ulla; Ginsburg, David; Lusher, Jeanne M.; High, Katherine A..

Hematology Am Soc Hematol Educ Program ; : 241-265, 2000.

Artículo en Inglés | MEDLINE | ID: mdl-11701545

Portal de Búsqueda de la BVS

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.

A longer acting rFVIII, safe and effective.

No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.

Emergency department visits in children with hemophilia.

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.

Thromboelastography in children with coagulation factor deficiencies.

Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia.

How do you treat bleeding disorders with desmopressin?

Milestones in hemophilia and concepts in future clinical trial design.

Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation.

Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonance.

A community-based partnership to promote information infrastructure for bleeding disorders.

Fibrinolytic parameters in children with noncatheter thrombosis: a pilot study.

Highlights from the XXV International Congress of the World Federation of Hemophilia. May 19-24, 2002, Seville, Spain.

Evolution of recombinant factor VIII safety: KOGENATE and Kogenate FS/Bayer.

Pediatric reference values for molecular markers in hemostasis.

The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B.

First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor development.

Congenital Hemorrhagic Disorders: New Insights into the Pathophysiology and Treatment of Hemophilia.